BR9713388A - Processos de produção de vìrus e de adenovìrus recombinantes defectivos, baculovìrus recombinante, e, preparação viral purificada - Google Patents
Processos de produção de vìrus e de adenovìrus recombinantes defectivos, baculovìrus recombinante, e, preparação viral purificadaInfo
- Publication number
- BR9713388A BR9713388A BR9713388A BR9713388A BR9713388A BR 9713388 A BR9713388 A BR 9713388A BR 9713388 A BR9713388 A BR 9713388A BR 9713388 A BR9713388 A BR 9713388A BR 9713388 A BR9713388 A BR 9713388A
- Authority
- BR
- Brazil
- Prior art keywords
- adenoviruses
- production processes
- recombinant
- purified viral
- viral preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
- C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pens And Brushes (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
-se a um processo para produzir vírus recombinante. Este processo é baseado no uso de baculovírus pa refere a construções usadas para implementar este processo, a produção de células, e o vírus resultante.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9614278A FR2756297B1 (fr) | 1996-11-22 | 1996-11-22 | Procede de production de virus recombinants |
PCT/FR1997/002073 WO1998022607A1 (fr) | 1996-11-22 | 1997-11-18 | Procede de production de virus recombinants |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9713388A true BR9713388A (pt) | 2000-03-21 |
BR9713388B1 BR9713388B1 (pt) | 2009-01-13 |
Family
ID=9497899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9713388-4A BR9713388B1 (pt) | 1996-11-22 | 1997-11-18 | processos de produÇço de vÍrus e de adenovÍrus recombinantes defectivos, e baculovÍrus recombinante. |
Country Status (18)
Country | Link |
---|---|
US (2) | US6387670B1 (pt) |
EP (1) | EP0946741B1 (pt) |
JP (1) | JP4686670B2 (pt) |
KR (1) | KR100719645B1 (pt) |
AT (1) | ATE317908T1 (pt) |
AU (1) | AU731106B2 (pt) |
BR (1) | BR9713388B1 (pt) |
CA (1) | CA2271438C (pt) |
CZ (1) | CZ293947B6 (pt) |
DE (1) | DE69735274T2 (pt) |
ES (1) | ES2260803T3 (pt) |
FR (1) | FR2756297B1 (pt) |
HU (1) | HU224713B1 (pt) |
IL (1) | IL129686A (pt) |
NO (2) | NO323937B1 (pt) |
SK (1) | SK286900B6 (pt) |
WO (1) | WO1998022607A1 (pt) |
ZA (1) | ZA9710516B (pt) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2375119A1 (en) * | 1999-05-27 | 2000-12-07 | Genovo, Incorporated | Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus |
US6793926B1 (en) | 1999-05-27 | 2004-09-21 | Genovo, Inc. | Methods for production of a recombinant adeno-associated virus |
AU5448400A (en) * | 1999-05-28 | 2000-12-18 | Mount Sinai School Of Medicine, The | A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors |
GB9919409D0 (en) | 1999-08-18 | 1999-10-20 | Univ Oxford Brookes | Baculovirus expression system |
JP2006515162A (ja) | 2002-08-29 | 2006-05-25 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 環状核酸ベクター、ならびに同ベクターの作製法および使用法 |
GB0702695D0 (en) * | 2007-02-12 | 2007-03-21 | Ark Therapeutics Ltd | Production of vectors |
GB0702694D0 (en) * | 2007-02-12 | 2007-03-21 | Ark Therapeutics Ltd | Vectors |
EP2019143A1 (en) | 2007-07-23 | 2009-01-28 | Genethon | CNS gene delivery using peripheral administration of AAV vectors |
EP2058401A1 (en) | 2007-10-05 | 2009-05-13 | Genethon | Widespread gene delivery to motor neurons using peripheral injection of AAV vectors |
EP2249950B1 (en) * | 2008-03-05 | 2014-10-15 | Council of Scientific & Industrial Research | A polymeric hybrid membrane |
EP2287323A1 (en) | 2009-07-31 | 2011-02-23 | Association Institut de Myologie | Widespread gene delivery to the retina using systemic administration of AAV vectors |
EP2292781A1 (en) | 2009-08-17 | 2011-03-09 | Genethon | Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions |
CN102884196B (zh) * | 2010-04-01 | 2015-05-06 | 肖卫东 | 重组病毒载体的结构及其制备 |
JP2013523175A (ja) | 2010-04-14 | 2013-06-17 | イーエムディー・ミリポア・コーポレーション | 高力価、高純度のウイルスストックの作製方法及びその使用方法 |
US9677088B2 (en) | 2012-05-09 | 2017-06-13 | Oregon Health & Science University | Adeno associated virus plasmids and vectors |
TWI702955B (zh) | 2012-05-15 | 2020-09-01 | 澳大利亞商艾佛蘭屈澳洲私營有限公司 | 使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd) |
CA2877428A1 (en) | 2012-06-21 | 2013-12-27 | Association Institut De Myologie | Widespread gene delivery of gene therapy vectors |
EP3039129B1 (en) * | 2013-08-30 | 2018-06-27 | Amgen Inc. | High titer recombinant aav vector production in adherent and suspension cells |
AU2015231439B2 (en) | 2014-03-17 | 2019-11-14 | Adverum Biotechnologies, Inc. | Compositions and methods for enhanced gene expression in cone cells |
KR20170137730A (ko) | 2015-03-02 | 2017-12-13 | 애드베룸 바이오테크놀로지스, 인코포레이티드 | 망막 추상체에 폴리뉴클레오타이드의 유리체 내 전달을 위한 조성물 및 방법 |
GB2545763A (en) | 2015-12-23 | 2017-06-28 | Adverum Biotechnologies Inc | Mutant viral capsid libraries and related systems and methods |
JP2021503960A (ja) | 2017-11-27 | 2021-02-15 | コーダ バイオセラピューティクス, インコーポレイテッド | 神経疾患のための組成物および方法 |
US10610606B2 (en) | 2018-02-01 | 2020-04-07 | Homology Medicines, Inc. | Adeno-associated virus compositions for PAH gene transfer and methods of use thereof |
WO2019161365A1 (en) | 2018-02-19 | 2019-08-22 | Homology Medicines, Inc. | Adeno-associated virus compositions for restoring f8 gene function and methods of use thereof |
WO2020160508A1 (en) | 2019-01-31 | 2020-08-06 | Oregon Health & Science University | Methods for using transcription-dependent directed evolution of aav capsids |
WO2021035179A1 (en) | 2019-08-21 | 2021-02-25 | Coda Biotherapeutics, Inc. | Compositions and methods for neurological diseases |
TW202140791A (zh) | 2020-01-13 | 2021-11-01 | 美商霍蒙拉奇醫藥公司 | 治療苯酮尿症之方法 |
GB202013940D0 (en) | 2020-09-04 | 2020-10-21 | Synpromics Ltd | Regulatory nucleic acid sequences |
JP2023545731A (ja) | 2020-10-07 | 2023-10-31 | アスクレピオス バイオファーマシューティカル, インコーポレイテッド | 肢帯型2i(lgmd2i)を含むジストログリカノパチー障害を処置するためのフクチン関連タンパク質(fkrp)の治療的アデノ随伴ウイルス送達 |
WO2023212298A1 (en) | 2022-04-29 | 2023-11-02 | Broadwing Bio Llc | Bispecific antibodies and methods of treating ocular disease |
WO2023212294A1 (en) | 2022-04-29 | 2023-11-02 | Broadwing Bio Llc | Angiopoietin-related protein 7-specific antibodies and uses thereof |
WO2023212293A1 (en) | 2022-04-29 | 2023-11-02 | Broadwing Bio Llc | Complement factor h related 4-specific antibodies and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0441897A4 (en) * | 1988-11-14 | 1992-06-24 | Us Health | Parvovirus capsids |
US5559099A (en) * | 1994-09-08 | 1996-09-24 | Genvec, Inc. | Penton base protein and methods of using same |
AU702830B2 (en) * | 1994-09-23 | 1999-03-04 | General Hospital Corporation, The | Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
-
1996
- 1996-11-22 FR FR9614278A patent/FR2756297B1/fr not_active Expired - Lifetime
-
1997
- 1997-11-18 BR BRPI9713388-4A patent/BR9713388B1/pt not_active IP Right Cessation
- 1997-11-18 DE DE69735274T patent/DE69735274T2/de not_active Expired - Lifetime
- 1997-11-18 JP JP52328298A patent/JP4686670B2/ja not_active Expired - Lifetime
- 1997-11-18 AU AU52261/98A patent/AU731106B2/en not_active Expired
- 1997-11-18 CZ CZ19991822A patent/CZ293947B6/cs not_active IP Right Cessation
- 1997-11-18 HU HU0001762A patent/HU224713B1/hu active Protection Beyond IP Right Term
- 1997-11-18 WO PCT/FR1997/002073 patent/WO1998022607A1/fr active IP Right Grant
- 1997-11-18 CA CA2271438A patent/CA2271438C/fr not_active Expired - Lifetime
- 1997-11-18 AT AT97947083T patent/ATE317908T1/de not_active IP Right Cessation
- 1997-11-18 US US09/308,398 patent/US6387670B1/en not_active Expired - Lifetime
- 1997-11-18 ES ES97947083T patent/ES2260803T3/es not_active Expired - Lifetime
- 1997-11-18 KR KR1019997004531A patent/KR100719645B1/ko not_active IP Right Cessation
- 1997-11-18 EP EP97947083A patent/EP0946741B1/fr not_active Expired - Lifetime
- 1997-11-18 IL IL12968697A patent/IL129686A/xx not_active IP Right Cessation
- 1997-11-18 SK SK666-99A patent/SK286900B6/sk not_active IP Right Cessation
- 1997-11-21 ZA ZA9710516A patent/ZA9710516B/xx unknown
-
1999
- 1999-05-21 NO NO19992464A patent/NO323937B1/no not_active IP Right Cessation
-
2002
- 2002-05-09 US US10/141,491 patent/US20030022356A1/en not_active Abandoned
-
2013
- 2013-04-15 NO NO2013009C patent/NO2013009I1/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL129686A0 (en) | 2000-02-29 |
CZ182299A3 (cs) | 1999-08-11 |
IL129686A (en) | 2005-12-18 |
HUP0001762A2 (hu) | 2000-09-28 |
KR20000057202A (ko) | 2000-09-15 |
SK286900B6 (sk) | 2009-07-06 |
AU5226198A (en) | 1998-06-10 |
KR100719645B1 (ko) | 2007-05-17 |
ATE317908T1 (de) | 2006-03-15 |
CZ293947B6 (cs) | 2004-08-18 |
FR2756297B1 (fr) | 1999-01-08 |
HU224713B1 (en) | 2006-01-30 |
FR2756297A1 (fr) | 1998-05-29 |
US6387670B1 (en) | 2002-05-14 |
SK66699A3 (en) | 2000-02-14 |
CA2271438A1 (fr) | 1998-05-28 |
NO992464D0 (no) | 1999-05-21 |
NO2013009I1 (no) | 2013-04-29 |
NO992464L (no) | 1999-06-23 |
DE69735274T2 (de) | 2006-10-12 |
JP4686670B2 (ja) | 2011-05-25 |
NO323937B1 (no) | 2007-07-23 |
AU731106B2 (en) | 2001-03-22 |
HUP0001762A3 (en) | 2002-01-28 |
ES2260803T3 (es) | 2006-11-01 |
JP2001503993A (ja) | 2001-03-27 |
WO1998022607A1 (fr) | 1998-05-28 |
BR9713388B1 (pt) | 2009-01-13 |
CA2271438C (fr) | 2010-10-26 |
DE69735274D1 (de) | 2006-04-20 |
EP0946741B1 (fr) | 2006-02-15 |
ZA9710516B (en) | 1998-06-10 |
EP0946741A1 (fr) | 1999-10-06 |
US20030022356A1 (en) | 2003-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9713388A (pt) | Processos de produção de vìrus e de adenovìrus recombinantes defectivos, baculovìrus recombinante, e, preparação viral purificada | |
BR0016390A (pt) | Componente piezelétrico | |
ATE353017T1 (de) | Herstellung von impstoffen zür vorbeugung von pathogenen zuständen einer hiv retroviraler infektion | |
BR9006422A (pt) | Processo para preparar um polipeptidio viral pt-nanbh e processo para detectar o mesmo | |
BR9710030A (pt) | Processo de produção de adenovírus recombinantes processo de purificação de adenovírus recombinantes a partir de um meio biológico preparação viral purificada composição farmacêutica e utilização de iodixanol-5,5'-[(2-Hidroxipropil-1,3-Propanottl)-Bis[N,N'-Bis(2,3-Didroxipropil-2,4,6-Triodo-1,3-Benzenocarboxamida] | |
ATE236262T1 (de) | Rekombinanter schweinepocken-virus | |
BR9814606A (pt) | Formulação de vacina e métodos de tratamento de um indivìduo infectado com um vìrus hpv e de prevenção de infecção por papiloma vìrus | |
CA2072573A1 (en) | Treatment of human retroviral infections with 2',3'-dideoxyinosine | |
CL2004000031A1 (es) | Compuestos derivados de n-arilamidas de acidos sulfonilamino carboxilicos sustituidos con azufre; composicion farmaceutica; procedimiento de preparacion; y uso del compuesto para tratar la hipertension, angina de pecho, restenosis, infarto al miocard | |
CA2258217A1 (en) | Substituted cyclopentane compounds useful as neuraminidase inhibitors | |
DE3853422D1 (de) | HIV-3-Retrovirus und seine Verwendung. | |
PT102022A (pt) | Processo para a producao e purificacao de astaloglicoprotetinas adequadas para uso em vacinas e conjunto de materiais de ensaio para detectar a sua presenca | |
ES2078255T3 (es) | Regiones inmunogenas en la proteina e-7 del papilomavirus humano tipo 16. | |
BR9910990B1 (pt) | processo para a preparaÇço de uma dextrina de amido, dextrina de amido, adesivo, papel, e, uso de uma dextrina de amido. | |
ES2121714T1 (es) | Herramienta de corte ceramica reforzada con filamentos, y su composicion. | |
BR9007965A (pt) | Estruturas laminadas contendo adesivo,polimeros grafitizados aqueciveis por rf e misturas | |
ATE164853T1 (de) | Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids | |
DE68910008D1 (de) | Polymetallosilazane, verwendbar zur Herstellung von keramischen Fibern auf der Basis von Siliziumnitrid. | |
CA2015608A1 (en) | Alumina-titanium carbide-silicon carbide composition | |
ES2078971T3 (es) | Produccion de virus y purificacion de proteinas con envoltura virica para uso en vacunas. | |
BR9913649A (pt) | Rede anelar wdm | |
DE69021625D1 (de) | Breitband-Koppelfeld mit deaktivierten Koppelpunkten zur Herstellung von Vermittlungswegen. | |
HUP9800113A2 (hu) | Transzgenikus vírus | |
DK0885013T3 (da) | Anvendelse af multipotente paramunitetsinducere fra svækkede, ikke-immunogene poxvirus eller parapoxvirus til fremstilling af lægemidler | |
AU6551800A (en) | Dinucleoside 5',5'-tetraphosphates as inhibitors of viral reverse transcriptasesand viruses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved | ||
B25A | Requested transfer of rights approved |
Free format text: GENCELL S.A. (FR) |
|
B25D | Requested change of name of applicant approved |
Owner name: GENCELL SAS (FR) Free format text: ALTERADO DE: GENCELL S.A. |
|
B25D | Requested change of name of applicant approved |
Owner name: CENTELION (FR) Free format text: ALTERADO DE: GENCELL SAS |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/03/2009, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 10.03.2019 |